Ajanta Pharma slips after US FDA issues form 483 to Dahej facility

Ajanta Pharma fell 1.61% to Rs 1372.60 after the company announced that the US FDA had issued Form 483 was issued to us with 2 observations after the inspection of its Dahej facility.